Ang P. Huang
Beijing, 100039, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Psoralidin induces pyroptosis in both tumor cells and macrophages as well as enhances nature killer cell cytotoxicity to suppress hepatocellular carcinoma.
Journal: Molecular immunology
Published: April 29, 2025
Kurarinone Alleviates cGAS-STING-Triggered Inflammatory Diseases by Targeting STING.
Journal: Phytotherapy research : PTR
Published: January 27, 2025
Quercetagetin alleviates liver fibrosis in non-alcoholic fatty liver disease by promoting ferroptosis of hepatic stellate cells through GPX4 ubiquitination.
Journal: Chinese medicine
Published: December 13, 2024
Analysis of Immunometabolic Profiles in Patients With Chronic Drug-Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms.
Journal: Journal of gastroenterology and hepatology
Published: August 17, 2024
An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 29, 2023
Prevalence and prediction of hepatocellular carcinoma in alcohol-associated liver disease: a retrospective study of 136 571 patients with chronic liver diseases.
Journal: eGastroenterology
Published: October 05, 2023
Clinical characteristics and prognosis of non-APAP drug-induced acute liver failure: a large multicenter cohort study.
Journal: Hepatology international
Published: February 02, 2023
Editorial: chronic DILI and HILI-corticosteroid plus glycyrrhizin as standard therapy? Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 10, 2022
Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury.
Journal: Frontiers in pharmacology
Published: May 02, 2022
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
Journal: Alimentary pharmacology & therapeutics
Published: September 20, 2021
Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
Journal: Hepatology (Baltimore, Md.)
Published: February 10, 2021
Last Updated: 09/26/2026